In this episode, 2 HIV experts from the Asia-Pacific region share their thoughts on some of the most important new insights from HIV treatment and prevention research over the past year.Specifically, the faculty discuss the role of newer innovations in HIV, including 2-drug oral antiretroviral therapy (ART) regimens, 2-drug long-acting injectable ART, and long-acting HIV pre-exposure prophylaxis in HIV care in the Asia-Pacific region, as well as the implications of weight gain with ART and important considerations related to the unique challenges associated with caring for the aging population of people with HIV in the region.Presenters:Anchalee Avihingsanon, MD, PhDHIV-NAT, Thai Red Cross AIDS Research CentrePathumwan, Bangkok, Thailand Senior Clinical TrialMedicineBangkok, ThailandReena Rajasuriar, BPharm, MPharm, PhDAssociate ProfessorDepartment of MedicineUniversity of MalayaKuala Lumpur, MalaysiaContent based on an online program supported by an independent educational grant from Gilead Sciences, Inc. andViiV Healthcare. Link to full program: bit.ly/3Hz0jNa Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related